Form 4 Tracker
Natera, Inc.
NTRA

118 insider filings · Latest: Aug 10, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 1, 2026Jun 3 8:40 PMRoelof BothaDirector
Sale
78,000$220.31$17.2M1,076,198(I)

View →

Jun 1, 2026Jun 1 8:12 PMBV369 TRUST
Proposed Sale
78,000$220.31$17.2M

View →

Jun 1, 2026Jun 1 8:05 PMSOLOMON MOSHKEVICH
Proposed Sale
3,000$218.43$655.3K

View →

May 26, 2026May 29 1:05 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Sale
1,652$202.84$335.1K140,643(D)

View →

May 26, 2026May 29 1:05 AMJohn FeskoPRESIDENT, CHIEF BUS. OFFICER
Sale
1,438$202.84$291.7K185,782(D)

View →

May 13, 2026May 16 1:05 AMJonathan SheenaDirector, Other
Sale
1,500$201.56$302.3K19,532(I)

View →

May 8, 2026May 16 1:05 AMJonathan SheenaDirector, Other
Sale
3,150$208.60$657.1K252,502(D)

View →

May 5, 2026May 7 1:35 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Sale
6,986$213.77$1.5M2,377,843(D)

View →

May 4, 2026May 7 1:35 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Sale
722$206.16$148.8K2,382,440(D)

View →

May 4, 2026May 6 1:45 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Sale
482$210.49$101.5K57,496(D)

View →

May 1, 2026May 6 1:45 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Sale
313$206.16$64.5K57,978(D)

View →

May 1, 2026May 6 1:35 AMJonathan SheenaDirector, Other
Sale
107$206.16$22.1K255,652(D)

View →

May 1, 2026May 6 1:35 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Sale
3,405$203.69$693.6K142,295(D)

View →

May 1, 2026May 6 1:35 AMJohn FeskoPRESIDENT, CHIEF BUS. OFFICER
Sale
291$206.16$60.0K187,220(D)

View →

May 1, 2026May 6 1:35 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Sale
902$206.16$186.0K149,867(D)

View →

May 1, 2026May 6 1:35 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Sale
330$206.16$68.0K222,694(D)

View →

May 4, 2026May 4 8:52 PMMICHAEL BROPHY
Proposed Sale
482$207.28$99.9K

View →

May 1, 2026May 1 8:08 PMSOLOMON MOSHKEVICH
Proposed Sale
3,000$203.36$610.1K

View →

Apr 29, 2026Apr 30 1:45 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Sale
3,070$193.74$594.8K58,291(D)

View →

Apr 27, 2026Apr 30 1:45 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Sale
1,993$204.14$406.9K61,361(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 5, 2026Jun 10 1:05 AMGail Boxer MarcusDirector
Option Exercise
11,000$22.8311,000(D)

View →

Apr 6, 2026Apr 9 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
58,292$9.590(D)

View →

Mar 31, 2026Apr 2 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
41,708$9.5958,292(D)

View →

Mar 16, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
50,000$9.59100,000(D)

View →

Mar 13, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
75,000$9.59150,000(D)

View →

Mar 12, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
75,000$9.59225,000(D)

View →

Mar 6, 2026Mar 11 1:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Option Exercise
5,598$19.680(D)

View →

Mar 2, 2026Mar 4 2:05 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Option Exercise
5,125$9.590(D)

View →

Jan 20, 2026Jan 23 2:35 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Option Exercise
3,3860(D)

View →

Jan 20, 2026Jan 23 2:35 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Option Exercise
1,5220(D)

View →

Jan 20, 2026Jan 23 2:05 AMJonathan SheenaDirector, Other
Option Exercise
1910(D)

View →

Jan 20, 2026Jan 23 2:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Option Exercise
8560(D)

View →